Results 71 to 80 of about 181,406 (245)
, 2017 Due to the unavailability of horse antithymocyte globulin (ATG) in many markets worldwide, patients with severe aplastic anemia (SAA) are limited to the use of rabbit ATG.
盧孟佑 +1 more
core +1 more source
Cancer incidence in relatives of British Fanconi Anaemia patients. [PDF]
, 2008 BACKGROUND: Fanconi anemia (FA) is an autosomal recessive DNA repair disorder with affected individuals having a high risk of developing acute myeloid leukaemia and certain solid tumours. Thirteen complementation groups have been identified and the genes
Ball Jan +14 more
core +3 more sources
The combination of karyotype analysis, HbF and p53 immunostaining is useful for the differential diagnosis between refractory anemia and aplastic anemia. [PDF]
, 2008 名古屋大学NAGOYA University博士(医療技術学)P53 mutation has been reported in various solid tumors, acute leukemia and myelodysplastic syndrome (MDS). However, the diagnostic significance of p53 in MDS remains to be determined.
Iwasaki, Takashi, 岩崎, 卓識
core
Annals of Hepatology, 2010 Aplastic anemia following viral hepatitis is a condition well recognized in the medical literature. Although hepatitis-associated aplastic anemia is an uncommon syndrome, there are several reports in the literature describing such cases. In these reports,
Nawal Al Nahdi +3 more
doaj +1 more source
Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group [PDF]
Blood, 1991 The annual incidence of aplastic anemia in metropolitan Bangkok, Thailand, and its five suburban provinces was prospectively determined. All patients first diagnosed during the period from January through December 1989 who met specific clinical and pathologic criteria were included. Thirty-two cases were identified, yielding an overall incidence of 3.7
S, Issaragrisil +9 more
openaire +3 more sources
APLASTIC ANEMIA ET CAUSA OF SUSPECT VIRAL HEPATITIS INFECTION: A CASE REPORT
e-Jurnal Medika Udayana, 2014 Aplastic anemia is anemia that occurs because of a failure of hematopoiesis is relatively rarebut can be life threatening. The cause of aplastic anemia itself is still largely unknown oridiopathic.
I Wayan Wawan Lismana
doaj
Haematologica, 2011 Background Although the therapeutic outcome of acquired aplastic anemia has improved markedly with the introduction of immunosuppressive therapy using antithymocyte globulin and cyclosporine, a significant proportion of patients subsequently relapse and ...
Takuya Kamio +19 more
doaj +1 more source
Haematologica, 2015 Aplastic anemia is a rare but life-threatening disorder characterized by cytopenia in at least two of the three blood lineages. A frequent feature of patients with aplastic anemia is that they have shorter telomeres than those of age-matched controls ...
Christian Bär +3 more
doaj +1 more source
British Journal of Haematology, EarlyView.Summary While the majority of myeloid neoplasms are sporadic, the increasing application of germline genetic testing has led the World Health Organization to designate ‘Myeloid malignancies with germline predisposition’ as a distinct clinical entity, carrying major implications for clinical care and research.
Elena Vuelta +9 more
wiley +1 more source
Allogeneic Stem Cell Transplantation for Aplastic Anemia [PDF]
, 2007 Aplastic anemia encompasses a heterogeneous group of diseases with distinct pathophysiologies and a common clinical endpoint of marrow failure. Patients with severe aplastic anemia can be treated with immunosuppressive therapy (IST) or hematopoietic stem
Armand, Philippe, Antin, Joseph H.
core +1 more source